Measuring intestinal gases using the Atmo Gas Capsule in patients with inflammatory bowel disease
Not Applicable
- Conditions
- inflammatory bowel diseaseOral and Gastrointestinal - Inflammatory bowel disease
- Registration Number
- ACTRN12621000934842
- Lead Sponsor
- Atmo Biosciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
Participants being newly commenced on treatment of active inflammatory bowel disease, and are 18 years or older in age
Exclusion Criteria
Concurrent irritable bowel syndrome
Previous gastrointestinal surgery
Probiotics use
Indeterminate colitis
Implantable devices such as a pacemaker
Suspected or known strictures
Patients potentially requiring MRI after the capsule has been ingested
Pregnancy
Radiation enteritis
Gastric bezoar
Swallowing disorders / dysphagia to food or pills
Obese, with BMI over 35
Fistulas, or physiological/mechanical gastrointestinal obstruction
Diverticulitis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method